Skip to content

Hypoglycemia in post-bariatric vs. non-bariatric pregnancy: incidence and effects on fetal growth

Hypoglycemia in post-bariatric vs. non-bariatric pregnancy: incidence and effects on fetal growth - Hypo-baby

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56907
Enrollment
174
Registered
2024-07-30
Start date
2025-03-07
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypoglycemia low blood sugar

Interventions

None listed

Sponsors

Medisch Centrum Leeuwarden
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria: Pregnant, either after metabolic-bariatric surgery (Roux-en-Y gastric bypass or One anastomosis gastric bypass performed at CON, MCL with pre-surgery BMI >40, and post-BS total weight loss (TWL) of >20%), or without metabolic-bariatric surgery with BMI >40 or BMI between 18.5-24.9. At the time of inclusion, the subject must be between 6-10 weeks pregnant.

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: - Diagnosis with type 1 or type 2 diabetes before the pregnancy, or diagnosis with type 1 or type 2 diabetes or GDM before the BS. - Diagnosis with severe psychiatric or medical comorbidities known to potentially affect fetal growth (e.g. severe depression, lupus, chronic kidney disease). - Continued smoking, alcohol consumption, or substance use throughout the pregnancy. - Allergy for plasters. - Multiple pregnancy. - Pregnancy less than 12 months after bariatric surgery. - Post-bariatric total weight loss of

Design outcomes

Primary

MeasureTime frame
The main endpoint is the number of hypoglycemic events (fasting and postprandial) during post-bariatric pregnancies and non-bariatric pregnancies (with obese and healthy BMI).

Secondary

MeasureTime frame
The secondary study parameters are neonatal birthweight, gestational weight gain, placental weight and histology, micronutrient deficiency, and nu number of hyperglycemic events. Other parameters are data from the patient file (age, ethnicity, comorbidities, pre-bariatric weight).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)